Article title: Is flibanserinmeaningfully superior to placebo?
Authors: Anita H. Clayton, and Robert E. Pyke
Journal: Journal of Sex & Marital Therapy
Bibliometrics: Volume 43, Issue 3, 2017, pages 218–222
DOI:10.1080/0092623X.2017.1280865
The conflicts of interest should have included the following information: Anita H. Clayton received grants in the last 12 months from Axsome; Forest Research Institute, Inc., now Allergan; Janssen; Palatin Technologies; Sage; and Takeda. She received advisory board/consultant fees from Fabre-Kramer; Palatin 10 Technologies; S1 Biopharma; Sprout, a division of Valeant Pharmaceuticals; and Takeda. She received royalties/copyright from Ballantine Books/Random House; Changes in Sexual Functioning Questionnaire; and Guilford Publications. She also received shares/restricted stock units from Euthymics and S1 Biopharma.
The authors apologize for any inconvenience.